Literature DB >> 3872888

Reduced affinity of the androgen receptor for 5 alpha-dihydrotestosterone but not methyltrienolone in a form of partial androgen resistance. Studies on cultured genital skin fibroblasts.

L Pinsky, M Kaufman, A E Chudley.   

Abstract

We have studied a child with posterior labial fusion, clitoral phallus, female urethra, and a short, blind vagina born to a mother with decreased axillary and pubic hair. Her karyotype is 46,XY. At 2 yr of age, the child's basal level of plasma testosterone was less than 0.35 nM and after human chorionic gonadotropin stimulation, it rose to 2.6. Testis and epididymis histology were normal. Her cultured genital (labial) skin fibroblasts have normal testosterone 5 alpha-reductase activity, and metabolize 5 alpha-dihydrotestosterone (DHT) normally, but they do not augment (up-regulate) their basal androgen-receptor binding activity during prolonged incubation with DHT. With DHT, the androgen receptor in her genital skin fibroblasts has a normal binding capacity (maximum binding capacity = 25 fmol/mg protein), but an increased rate constant of dissociation (k = 11.6 X 10(-3) min-1; normal, 6 +/- 1.2 (+/- SD)), and a decreased apparent equilibrium binding affinity (Kd = 0.6 nM; normal, 0.22 +/- 0.09) that is evident in the results of 2-h assays but not of those lasting 0.5 h. With the synthetic androgen, methyltrienolone, all three binding properties of the receptor are normal, and her receptor activity up-regulates normally. We interpret these results to mean that the subject has a ligand-selective defect in the time-dependent transformation of initial, low-affinity androgen-receptor complexes to serial states of higher affinity, presumably as the result of a structural mutation at the X-linked locus that encodes the androgen receptor protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872888      PMCID: PMC425458          DOI: 10.1172/JCI111829

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Activation of steroid hormone-receptor complexes in intact target cells in physiological conditions.

Authors:  A Munck; R Foley
Journal:  Nature       Date:  1979-04-19       Impact factor: 49.962

2.  Glucocorticoid receptor in circulating mononuclear leukocytes.

Authors:  T Murakami; D Brandon; D Rodbard; D L Loriaux; M B Lipsett
Journal:  Endocrinology       Date:  1979-02       Impact factor: 4.736

3.  Defective up-regulation of the androgen receptor in human androgen insensitivity.

Authors:  M Kaufman; L Pinsky; R Feder-Hollander
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

4.  Comparison of methyltrienolone and dihydrotestosterone binding and metabolism in human genital skin fibroblasts.

Authors:  T R Brown; S W Rothwell; C J Migeon
Journal:  J Steroid Biochem       Date:  1981-10       Impact factor: 4.292

5.  Congenital androgen insensitivity due to a qualitatively abnormal androgen receptor.

Authors:  L Pinsky; M Kaufman; R L Summitt
Journal:  Am J Med Genet       Date:  1981

6.  Differences between oestrogen receptor activation by oestrogen and antioestrogen.

Authors:  H Rochefort; J L Borgna
Journal:  Nature       Date:  1981-07-16       Impact factor: 49.962

7.  Expression of androgen-responsive properties in human skin fibroblast strains of genital and nongenital origin.

Authors:  M Kaufman; C Straisfeld; L Pinsky
Journal:  Somatic Cell Genet       Date:  1977-01

Review 8.  Cultured human skin fibroblasts: a model for the study of androgen action.

Authors:  T R Brown; C J Migeon
Journal:  Mol Cell Biochem       Date:  1981-04-13       Impact factor: 3.396

9.  Defective activation of androgen-receptor complexes: a marker of androgen insensitivity.

Authors:  M Kaufman; L Pinsky; L Simard; S C Wong
Journal:  Mol Cell Endocrinol       Date:  1982-02       Impact factor: 4.102

10.  Studies of the locus for androgen receptor: localization on the human X chromosome and evidence for homology with the Tfm locus in the mouse.

Authors:  B R Migeon; T R Brown; J Axelman; C J Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.